Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov;10(Suppl 33):S4002-S4005.
doi: 10.21037/jtd.2018.09.25.

Taking care of the soldiers

Affiliations
Editorial

Taking care of the soldiers

Song Wan et al. J Thorac Dis. 2018 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Natural history of vein graft thickening, atherogenesis, and late failure: timeline and possible mechanisms involved. Modified with permission from Wan S, Yim AP, Angelini GD, Jeremy JY. Novel strategies for the prevention of vein graft failure. In: He GW, editor. Arterial grafting for coronary artery bypass surgery, 2nd edition. Springer-Verlag: Singapore, 2006:303-10.

Comment on

  • Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.
    Brilakis ES, Edson R, Bhatt DL, Goldman S, Holmes DR Jr, Rao SV, Shunk K, Rangan BV, Mavromatis K, Ramanathan K, Bavry AA, Garcia S, Latif F, Armstrong E, Jneid H, Conner TA, Wagner T, Karacsonyi J, Uyeda L, Ventura B, Alsleben A, Lu Y, Shih MC, Banerjee S; DIVA Trial Investigators. Brilakis ES, et al. Lancet. 2018 May 19;391(10134):1997-2007. doi: 10.1016/S0140-6736(18)30801-8. Epub 2018 May 11. Lancet. 2018. PMID: 29759512 Free PMC article. Clinical Trial.

References

    1. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013;381:629-38. 10.1016/S0140-6736(13)60141-5 - DOI - PubMed
    1. Campeau L, Enjalbert M, Lespérance J, et al. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years and 10 to 12 years after surgery. Circulation 1983;68:II1-7. - PubMed
    1. Jeremy JY, Zacharowski K, Shukla N, et al. Pharmacological strategies aimed at reducing complications associated with coronary artery bypass graft surgery. Curr Opin Pharmacol 2012;12:111-3. 10.1016/j.coph.2012.05.002 - DOI - PubMed
    1. Wan S, George SJ, Berry C, et al. Vein graft failure: current clinical practice and potential for gene therapeutics. Gene Ther 2012;19:630-6. 10.1038/gt.2012.29 - DOI - PubMed
    1. Dehmer GJ, Weaver D, Roe MT, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol 2012;60:2017-31. 10.1016/j.jacc.2012.08.966 - DOI - PubMed